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The expression of the X-CGD gene, which encodes the heavy-chain subunit of the phagocyte cytochrome b,
was studied during induced myeloid differentiation of HL-60 cells. Incubation of the cells with a combined
regimen of retinoic acid and dimethyl formamide resulted in granulocytic morphological differentiation and
acquisition of nitroblue tetrazolium reduction, a measure of superoxide generation. During the 5-day course of
induced differentiation, the levels of X-CGD mRNA transcripts rose 13-fold, with a 2-fold increase detectable
within 3 h of exposure to retinoic acid. Relative transcription rates for the X-CGD gene, determined by nuclear
runoff, increased two- to eightfold after 24 to 72 h of induced differentiation. However, the greater change in
X-CGD mRNA levels than that in transcription rates implies the involvement of posttranscriptional regulation
as well. Fractionation by centrifugal elutriation into phases of the cell cycle showed expression of X-CGD
transcripts predominantly in G, cells before induction and in all phases of the cell cycle 24 h after induction.
Thus the rapid increase in X-CGD expression in induced cells reflects the acquisition of functional competence
and not the concomitant cessation of proliferation or shift in cell cycle distribution.
Phagocytic cells such as granulocytes and macrophages
produce superoxide, peroxide, and other reactive oxygen
intermediates with microbicidal, tumoricidal, and inflamma-
tory effects (1, 28). The central reaction in this process is
catalyzed by a membrane-associated NADPH oxidase (2),
which transfers an electron to reduce molecular oxygen to
superoxide. The enzyme system is inactive in resting cells
but rapidly activates upon exposure of a phagocyte to a
variety of particulate and soluble stimuli that act though
several alternative pathways of transmembrane signal trans-
duction (27). The exact structure of the oxidase remains
unknown, but there is evidence to suggest that it is a
transmembrane (4) electron transport system which includes
a unique, low-midpoint-potential cytochrome b (13) and
probably an FAD-containing flavoprotein (24).
Most studies of the superoxide-generating system have
utilized mature granulocytes, monocytes, and macrophages
harvested from peripheral blood or peritoneal exudates. The
induced differentiation of the HL-60 myeloid leukemia cell
line provides a useful in vitro model of myeloid development
(11, 29). The cell line, derived from a patient with acute
myeloid leukemia, undergoes a low rate (1 to 5% of cells) of
spontaneous myeloid differentiation in vitro (10). Incubation
with polar solvents (such as dimethyl sulfoxide and N,N-
dimethylformamide [DMF]), retinoic acid (RA), or a wide
variety of other agents (7, 9, 11) induces markedly increased
differentiation to morphologic myelocytes, metamyelocytes,
band forms, and polymorphonuclear leukocytes. Such dif-
ferentiated HL-60 cells are capable of most granulocyte
functions: chemotaxis, ingestion, respiratory burst activity,
and bacterial killing (12, 18, 29). Previous studies of super-
oxide generation in HL-60 cells have demonstrated the
* Corresponding author.
t Present address: Laboratory of Viral Oncology, The Rocke-
feller University, New York, NY 10021.
maturation of the NADPH oxidase, its cytochrome b com-
ponent, and the membrane potential response to cell activa-
tion (29, 30). However, examination of the molecular mech-
anisms of regulation of superoxide-generating activity has
not been possible until the present time because no oxidase-
related probes have been available.
Recently, molecular cloning of the X-CGD gene and its
cDNA has been accomplished (32), allowing identification of
the gene defective in the X-linked form of chronic granulo-
matous disease, a disorder in which phagocytes lack
NADPH oxidase activity (5, 14). The X-CGD gene product
is the heavy chain of neutrophil cytochrome b (15, 36), which
is a heterodimer (31, 33) composed of the 90-kilodalton
X-CGD-encoded glycoprotein and a 22-kilodalton nongly-
cosylated polypeptide (C. A. Parkos, M. C. Dinauer, L. E.
Walker, R. A. Allen, A. J. Jesaitis, and S. H. Orkin, Proc.
Nati. Acad. Sci. USA, in press).
The initial cloning of the X-CGD gene utilized and dem-
onstrated the up-regulation of its expression in DMF-in-
duced HL-60 cells. We have now further characterized the
expression, inducibility, and control of the X-CGD gene
during HL-60 granulocytic differentiation.
MATERIALS AND METHODS
Cell lines and culture conditions. HL-60 cells, originally
obtained from Robert Gallo (National Cancer Institute,
Bethesda, Md.), were passaged twice weekly in RPMI 1640
medium (GIBCO Laboratories) supplemented with 10%
heat-inactivated fetal calf serum, 5.0 U of penicillin per ml,
and 5 pig of streptomycin per ml and maintained in a 7%. CO2
atmosphere at 370C.
The cells were seeded at 2.5 x 105/ml, and inducers of
differentiation were added 24 h later. Induction was initiated
first by incubation with 106 M RA for 24 h, followed by the
addition of 60 mM DMF. We had previously established
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(K. A. Barker and P. E. Newburger, manuscript in prepara-
tion) that this regimen resulted in maximal granulocytic
maturation of HL-60 cells.
Cell counts were performed in a hemacytometer, and
viability was assessed by the ability of the cells to exclude
0.1% trypan blue dye. For morphological assessment of the
cells, slides were prepared by centrifugation of the cells in a
Shandon/Southern Cytospin centrifuge, stained with Wright-
Giemsa stain (Sigma Chemical Co.). and examined by phase
microscopy under oil immersion at x 1,000 magnification.
Five stages of granulocytic differentiation were distin-
guished: promyelocytes, myelocytes, metamyelocytes, band
cells, and polymorphonuclear leukocytes.
Isolation of peripheral blood granulocytes. Peripheral blood
was collected in acid-citrate-dextrose, and granulocytes
were purified by dextran and Ficoll-Hypaque sedimentation
as described previously (3). Contaminating erythrocytes
were removed by hypotonic lysis. The cells were washed
and suspended in phosphate-buffered saline, pH 7.4 (PBS).
NBT reduction. Superoxide generation was determined by
counting cells capable of reducing nitroblue tetrazolium
(NBT) dye (29). Cells (1.5 x 106), 750 [Li of PBS with 5 mM
glucose, 20 pI 0.2% NBT, and 50 pl of phorbol myristate
acetate (PMA; 2 mg/ml) in 1 mg of bovine serum albumin per
ml were incubated at 37°C for 20 min. The reaction was
stopped with ice-cold PBS. After a 10-s spin in a microfuge,
the supernatant was removed, and the pellet was suspended
in 10 pI of serum, smeared gently on a slide, fixed in
methanol, and stained with safranin. Two hundred cells were
examined microscopically for the presence of blue granules.
and cells with more than five blue granules were counted as
NBT positive.
Elutriation of HL-60 cells. HL-60 cells were fractionated
on the basis of buoyant density by centrifugal elutriation (22)
in a Beckman JE-6B elutriator rotor. Cells (5 x 108) in log
phase were pelleted and washed in sterile elutriation buffer
(PBS with 1.5% heat-inactivated newborn calf serum, 5 U of
penicillin per ml, and S ,ug of streptomycin per ml) at 40C.
Then 70% ethanol, sterile water, and elutriation medium
were pumped sequentially through the elutriation chamber
before calibration of the flow rate with elutriation medium.
For cell fractionation, the rotor speed was set at 2,800 rpm.
The buffer flow rate was adjusted to 15 ml/min, and the cells
were injected into the rotor over a period of 2 min. At this
flow rate, all cells were retained in the rotor, and 150 ml of
buffer was collected to remove debris. After this initial wash,
fractions were collected at increasing flow rates to collect
increasingly larger cells. The flow rates for undifferentiated
and 24-h RA-treated HL-60 cells were 35, 38, 42, and 45 ml/
min. The final fraction of cells was obtained by maintaining
the buffer flow rate at 45 ml/min and adjusting the rotor
speed to 2,000 rpm. A prefraction was always collected after
the load fraction, to be sure that differentiated cells would
not be included in the analyzed fractions. Two-day differen-
tiated HL-60 cells were loaded at a flow rate of 10 ml/min
with the rotor speed at 2,800 rpm, and fractions were
removed at 16, 32, 40, 45 ml/min; the final fraction was
collected by maintaining the pump at the setting for 45 ml/
min and adjusting the rotor speed to 2,000 rpm.
The collected fractions were maintained on ice throughout
the elutriation. After all fractions had been collected they
were centrifuged, the pellets were washed in PBS, and the
cells were counted. Differential stains and NBT assays were
done on each fraction.
Determination of cell cycle stage by flow cytometry. The
proportion of HL-60 cells in the G1, S, and G,-M phases of
the cell cycle was determined by simultaneous flow cytomet-
ric measurement of cellular DNA content and the amount of
bromodeoxyuridine incorporated into cellular DNA (16).
HL-60 cells (2 x 106) were incubated with 10 p.M bromo-
deoxyuridine in RPMI medium with 10% fetal calf serum for
30 min in 7% CO, at 370C. The cells were washed twice with
PBS, the pellet was suspended in 100 p.1 of normal saline,
and 2 ml of cold 70% ethanol was added with gentle
vortexing. Cellular DNA was denatured by addition of 2 ml
of 4 N HCI, and the cells were neutralized with 0.1 M
Na,B407. After centrifugation, 5 p.1 of fluoresceinated anti-
bromodeoxyuridine was added to the cells in 50 pRl of 0.5%
Tween 20-PBS: after a 30-min incubation with the antibody,
the cells were washed twice with the buffer. Propidium
iodide at a final concentration of 20 pug/ml was added to stain
total DNA, and the cells were analyzed on a FACS-440
fluorescence-activated cell sorter (Becton Dickinson), with a
488-nm excitation laser. Red fluorescence from propidium
iodide was read with a 620-nm-band-path filter, and green
fluorescence from fluorescein (anti-bromodeoxyuridine) was
read with a 520-nm-band-path filter.
cDNA clones. The human X-CGD cDNA probe used for
these studies is a 1,800-base-pair BglII restriction fragment,
representing much of the 3' untranslated region of the
message (32). The 800-base-pair cDNA C16 (catalase probe)
in PKY218 (8) was obtained from Gail Bruns (Harvard
Medical School). The third exon of c-mvc in pBR322,
originally obtained from Kathleen Kelly, was provided by
Susan Schiavi (University of Massachusetts Medical
School). The human glutathione peroxidase probe is a full-
length cDNA identified by oligonucleotide screening of an
HL-60 library (S. Chada and P. E. Newburger, J. Cell.
Biochem. 12A(Suppl.):B306, 1988). The human transferrin
receptor clone pTR-48, a partially characterized (8) 2-kilo-
base insert in puc9, was obtained from M. Greaves (Imperial
Cancer Research Fund, London).
cDNA probes were labeled by nick translation as previ-
ously described (26).
Northern blot analysis of RNA. RNA was extracted by the
guanidine hydrochloride method (20). Polyadenylated RNA
was further purified from whole cell HL-60 RNA by passage
over an oligo(dT)-cellulose column. For Northern (RNA)
blotting (26), whole cell or polyadenylated RNA was dena-
tured, electrophoresed in a 1.2% agarose-formaldehyde gel
in morpholinepropanesulfonic acid buffer, and then trans-
ferred to a 0.45-pum-pore-size filter of Zeta Probe (Bio-
Rad Laboratories). Prehybridization, hybridization, filter
washes, and filter stripping were performed as described
previously (19). Filters were dried at room temperature
before exposure to XAR film (Kodak) with Lightning-Plus
intensifying screens (Kodak) at -70°C. Densitometry of the
processed film was performed on a Quick-Scan R&D densi-
tometer (Helena Laboratories), and areas under the curves
were determined by the weight of cut-out chart paper.
Values for hybridization to control plasmid DNA were
subtracted from those for the plasmid with specific probe.
Southern blot analysis of HL-60 DNA. High-molecular-
weight DNA was isolated as previously described (26) from
cell nuclei (6) prepared from 107 to 108 cells. The DNA was
digested with restriction enzymes according to the instruc-
tions of the distributor; electrophoresis, hydrolysis. and
denaturation were performed by standard techniques (26).
Transfer, prehybridization, and hybridization procedures
were identical to those for Northern blots.
Nuclear runoff assay for transcription rates. Nuclear run-
offs were performed with minor modifications of the method
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developed for HL-60 cells (25). HL-60 cells were harvested,
washed once in cold PBS and once in reticulocyte standard
buffer (10 mM Tris [pH 7.4], 10 mM NaCl, 3 mM MgCl2) and
then lysed with 0.05% Nonidet P-40 in reticulocyte standard
buffer on ice for 5 min. The effectiveness of lysis was
checked by phase microscopy. Nuclei were collected by
centrifugation at 50 x g, washed twice in reticulocyte
standard buffer, and suspended in nuclear freezing buffer
(40% glycerol, 50 mM Tris [pH 8.3], 5 mM MgCl,, 0.1 mM
EDTA) before immediate use or freezing at -700C. At the
time of the assay, the nuclear suspensions received additions
of 20 RI1 of [a-32P]UTP (3,000 Ci/mmol; 10 p.Ci/pul) and 60 p.1
of runoff buffer (25 mM Tris [pH 8.0]; 12.5 mM MgCl2; 750
mM KCI; 1.25 mM each ATP, GTP, and CTP; 1 ,uM UTP;
100 jig of creatine phosphokinase; 5 mM dithiothreitol; and
20 mM phosphocreatine). After incubation for 30 min at
26°C, the reaction was stopped by addition of 5 p.1 of DNase
I (1 U/,ul) and 0.75 p.1 of 2 M CaCl,, followed by incubation
for 5 min at 26°C.
Newly synthesized RNA was then extracted and detected
as follows. To the above reaction mixture were added 10 p.1
of proteinase K (10 mg/ml) and 36 p.l of 10x buffer containing
10% sodium dodecyl sulfate, 50 mM EDTA, and 100 mM
Tris (pH 7.5); then the sample was incubated at 37°C for 45
min. The sample was extracted with phenol-chloroform, and
the nucleic acid was precipitated with ammonium acetate
(final concentration, 2.3 M) and an equal volume of isopro-
panol on dry ice for 20 min. After centrifugation, the pellet
was suspended in water and precipitated with sodium ace-
tate (0.3 M) and 3 volumes of ethanol overnight at -20°C.
After centrifugation, the pellet was suspended in hybridiza-
tion buffer (see below), and the trichloroacetic acid-precipi-
table 32P radioactivity was determined. Equal counts for
each sample within an experiment, usually 3 x 106 to 8 x 106
cpm, were then used for hybridizations as follows.
Specific sequences synthesized in the reaction were de-
tected by hybridization to nonlabeled cDNA probe immobi-
lized on filters. The cDNA was denatured by boiling for 10
min and then applied to Zeta-probe filters with sterile dis-
tilled water in a Schleicher & Schuell slot-blot apparatus.
Preliminary experiments established that the amounts of
probe, 5 to 8 ,ug per slot, were above the saturation point for
complete binding of the runoff mRNA. Filters were baked
for 2 h and prehybridized overnight at 65°C in 10 mM Tris
(pH 7.4), 0.4% (wt/vol) polyvinylpyrrolidone, 0.4% (wt/vol)
Ficoll 400, 1 mg of salmon sperm DNA per ml, 1% sodium
pyrophosphate, and 0.2% sodium dodecyl sulfate. Filters
were then hybridized with the labeled, newly synthesized,
RNA for 36 to 48 h at 65°C in 10 mM Tris (pH 7.4), 0.04%
polyvinylpyrrolidone, 0.04% Ficoll 400, 0.1 mg of salmon
sperm DNA per ml, 1% sodium pyrophosphate, and 0.2%
sodium dodecyl sulfate. After hybridization, the filters were
washed at 65°C for 1 h, once with 1 x SSC (0.15 M NaCl plus
0.015 M sodium citrate)-0.1% sodium dodecyl sulfate and
twice with 0.1 x SSC-0.1% sodium dodecyl sulfate, and then
dried at room temperature and exposed to Kodak XAR film
with an intensifying screen at -70°C for various times.
Hybridization signals on developed films were quantitated
by visible light densitometry. The scans were cut out and
weighed to derive the area under each density curve, and the
data were corrected for nonspecific hybridization by sub-
traction of the value for the plasmid (pBR322) probe.
RESULTS
Initial studies of the tissue distribution of X-CGD gene
expression (32) had shown transcripts to be present only in
a_
+
z z
Z
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FIG. 1. X-CGD mRNA expression in peripheral blood mononu-
clear cells (M) (lane 1) and granulocytes (PMN) (lanes 2 and 3). The
cells were isolated from human peripheral blood and granulocytes
incubated for 20 min without (lane 2) or with (lane 3) PMA (2 pug/ml)
before isolation of whole cell RNA and Northern blot analysis,
performed as described in Materials and Methods.
cultured human monocyte-derived macrophages, the HL-60
cell line, and (at a much lower level) in transformed normal
B-cell lines. Before studying the development of X-CGD
gene expression in granulocytic HL-60 cells, we first exam-
ined mature human peripheral blood cells to demonstrate the
presence of X-CGD mRNA in granulocytes. X-CGD gene
transcripts were present in both fresh peripheral blood
granulocytes and monocytes in a Northern blot (Fig. 1).
Incubation of the granulocytes with PMA at concentrations
that activate superoxide release did not result in increased
levels of X-CGD message, indicating that PMA stimulation
of oxidase activity is not regulated at the level of X-CGD
mRNA abundance. The percentage of NBT-positive cells
was 1% for the resting granulocytes and 99%o for granulo-
cytes stimulated by PMA.
DNA isolated from HL-60 cells was cut by several restric-
tion endonucleases and examined on Southern blots for
hybridization with a 0.3-kilobase restriction fragment from
the 3' untranslated region of X-CGD cDNA (32). In HL-60
DNA cut with PstI, EcoRI, or HindIII, only one band
hybridized with the probe, suggesting that the X-CGD gene
is present as a single copy in HL-60 cells (data not shown).
To define the inducibility of the X-CGD gene, HL-60 cells
were treated with a sequential RA-DMF induction regimen
for 5 days. During RA-DMF treatment, both DNA and RNA
synthesis decreased almost to background levels (34). This
treatment resulted in effective granulocytic differentiation,
as shown by differential cell counts (Table 1). When RNA,
extracted from HL-60 cells during 5 days of treatment with
RA-DMF, was hybridized with labeled X-CGD probe, low-
level hybridization was discernable on day 0. The X-CGD
signal doubled by day 1 and was increased 10-fold by day 2
and 13-fold by day 4 of differentiation; hybridization re-
mained high (8-fold above that at day 0) even at 5 days of
differentiation (Fig. 2A). This rise in X-CGD mRNA accom-
panied an increase in oxidase activity, as measured by the
ability of the cells to reduce NBT (Fig. 2B).
Because of the rapidity of induction of the X-CGD mes-
sage, we examined the expression of the message during a
shorter incubation with inducing agent. HL-60 cells were
incubated with RA for 24 h, RNA was extracted from the
cells at intermediate time points, and Northern transfers
were probed with X-CGD cDNA (Fig. 3A). X-CGD hybrid-
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TABLE 1. HL-60 cells incubated with RA-DMF treatment:
differential counts"
% of cells of indicated type on day:
Cell type
0 1 2 3 4
Promyelocyte 96 83 43 19 2
Myelocyte 4 14 41 46 18
Metamyelocyte 0 3 15 30 42
Band 0 0 1 5 34
PMNW 0 0 0 0 4
" HL-60 cells incubated for the indicated number of days with a sequential
induction regimen of RA-DMF (see Materials and Methods) were harvested
for differential cell counts on Wright-Giemsa-stained cytocentrifuge slides.6 PMN, polymorphonuclear leukocyte.
ization increased during 24 h, rising almost twofold by 3 h
and fivefold by 24 h. This increase in the level of X-CGD
transcripts correlated with the similarly early appearance of
cells capable of superoxide generation, measured by NBT
reduction (Fig. 3B).
To elucidate the mechanisms of regulation of the steady-
state levels of X-CGD mRNA, nuclear runoff transcription
assays were performed on cells before and at several times
during differentiation. The autoradiograph from one such
experiment (Fig. 4) demonstrates the rise in transcription of
X-CGD during 3 days of differentiation with RA-DMF,
compared with the probes pBR322 (plasmid control), gluta-
thione peroxidase cDNA (which is down-regulated [S.
Chada, C. Whitney, J. Wright, and P. E. Newburger, J. Cell.
Biochem. 12A:B308, 1988]), and catalase (which varies little
A
Day 0 1 2 3 4 5
-283
B 60-
a)
> 50-
g3 40-0
a_ 30-
z 20-
z
,i; 10-1
0 1 2 3 4 5
Days
FIG. 2. (A) X-CGD mRNA expression in HL-60 cells induced to
differentiate for 5 days with RA-DMF. Whole cell RNA was isolated
from HL-60 cells harvested on the indicated days of differentiation.
and Northern blot analysis with X-CGD cDNA was performed as
described in Materials and Methods. (B) NBT reduction by HL-60
cells induced to differentiate for 5 days with RA-DMF. At the
indicated days of differentiation, cells were examined for NBT
reduction as described in Materials and Methods.
A
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FIG. 3. (A) X-CGD mRNA expression in HL-60 cells induced to
differentiate for 24 h with RA. Whole cell RNA was isolated from
cells harvested at the indicated hours after RA addition and then
analyzed by Northern blotting as described in Materials and Meth-
ods. (B) NBT reduction by HL-60 cells induced to differentiate for
24 h with RA. At the indicated hours of differentiation, cells were
examined for NBT reduction as described in Materials and Meth-
ods.
in activity during HL-60 differentiation [35; Chada et al., J.
Cell. Biochem. 12A:B308, 1988]). Table 2 shows the relative
transcription rates of the X-CGD gene, plus control probes
for catalase and of c-myc (which rapidly decreases in expres-
sion upon induction of differentiation [21]). X-CGD tran-
scription increased nearly 2-fold after 1 or 2 days of induc-
tion, and 2.4- to 8-fold after 3 or 4 days. Concomitantly, the
rate of transcription of c-myc decreased, as expected, to an
undetectable level, and that of catalase decreased only
slightly.
One interpretation of these data might be that the increase
in X-CGD expression is due only to perturbation of the
HL-60 cell cycle induced by RA-DMF, which (like any other
d.O d.1 d.3
-
_ X-CGD
PBR
_m GPx
CAT
FIG. 4. Effect of differentiation on transcription rates of HL-60
cells, measured by nuclear runoff assay. The autoradiograph shows
the amount of RNA transcribed in vitro by nuclei from cells induced
to differentiate for the indicated number of days. The labels on the
right indicate the gene products assayed: X-CGD; pBR322, plasmid
control for nonspecific binding (pBR); glutathione peroxidase (GPx);
and catalase (CAT). The filter was hybridized with total runoffRNA
from equal numbers (2 x 108) of nuclei which were prepared from
cells isolated on days (d) 0, 1, and 3 of induced differentiation and
which incorporated 9 x 106, 1.9 x 106, and 1.3 x 106 cpm of
[32P]uridine, respectively.
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TABLE 2. Effect of induction of differentiation on X-CGD
transcription rate"
Transcription rate (% of that on day 0) on day:
Expt Probe
0 1 2 3 4
1 X-CGD 7 13 (186) 17 (243)
c-mvc 43 25 (58) 0 (0)
2 X-CGD 17 30 (176)
c-myc 230 62 (27)
Catalase 25 17 (78)
3 X-CGD 47 177 (216) 383 (814)
Catalase 32 54 (169) 23 (72)
"Nuclei isolated from HL-60 cells at the indicated days of incubation with
RA-DMF were assayed by nuclear runoff for transcription of mRNA hybrid-
izing with the indicated probes, as described in Materials and Methods. Data
represent the areas under the curves of densitometer scans of the hybridiza-
tion filters, corrected for hybridization to control plasmid and expressed in
arbitrary units.
inducer of terminal differentiation) shifts the cell cycle
distribution into Go-G1. To determine the relationship be-
tween X-CGD gene expression and the cell cycle phases,
HL-60 cells were fractionated by centrifugal elutriation, and
the cell cycle distribution of each of five successive fractions
was determined by flow cytometric analysis of bromodeox-
yuridine uptake and DNA content (propidium iodide stain-
ing). RNA isolated from the cells of each fraction was
probed with X-CGD cDNA (Fig. 5). In uninduced cells (Fig.
SA), X-CGD transcripts appeared primarily in the first
fraction (enriched for G1-Go), probably representing gene
expression in the subpopulation of cells undergoing sponta-
neous differentiation. After 24 h in RA (Fig. 5B), all cell
fractions showed approximately equal X-CGD transcript
levels. Reprobing of the same filter with a cDNA for the
transferrin receptor showed the expected decrease in
expression (17) in the first (G1-GO) fraction (data not shown).
After 48 h in RA-DMF, differentiation had produced major
morphological changes in the distribution of myeloid cell
types, cell proliferation had greatly diminished, and super-
oxide-generating capacity had increased. With the centrifu-
gal elutriation protocol utilized in these studies, 48-h differ-
entiated cells fractionate less by stage of the cell cycle than
by degree of differentiation, with the more mature cells
eluting in the earlier fractions (30). X-CGD was expressed
strongly in all fractions but the last, which contained the few
remaining undifferentiating and mitotic cells (Fig. SC).
DISCUSSION
The recently cloned X-CGD gene (32) encodes one poly-
peptide chain of the cytochrome b component of the super-
oxide-generating NADPH oxidase of phagocytic cells (15,
35). To study the molecular basis of the development of
superoxide-generating activity during myeloid maturation,
we examined the expression, inducibility, and control of the
X-CGD gene during induced granulocytic differentiation of
the HL-60 human myeloid cell line.
The level of X-CGD transcripts increased during differen-
tiation and paralleled the increase in the numbers of cells
exhibiting respiratory burst activity (measured as NBT re-
duction). These results confirm and extend our previous data
obtained in the course of the cloning of the X-CGD gene (32).
Two interesting aspects of the rise in steady-state X-CGD
transcript levels were the rapidity of induction of the X-CGD
Fraction
12 3 4 5 1 2 :3 4
A B C
FIG. 5. X-CGD mRNA expression in HL-60 cells fractionated
by centrifugal elutriation. The fractions are numbered in order of
elution and represent enriched populations of G1-G0 cells in fraction
1 and G,-M in fraction 5, with S-phase cells in intermediate
fractions. (A) Uninduced HL-60 cells. (B) HL-60 cells induced to
differentiate for 24 h with in6M RA. (C) HL-60 cells treated with
RA-DMF for 2 days. Fractions 1, 2, and 3 contained NBT-positive
cells (i.e., capable of PMA-stimulated superoxide generation); frac-
tions 4 and 5 contained NBT-negative cells.
mRNA and the maintenance of high levels of X-CGD mRNA
late in the course of RA-DMF-induced differentiation, when
RNA synthesis is almost at background levels. The former
observation helps to explain the previous finding that the
increase in NBT-positive cells occurs even before any de-
tectable morphologic change in the induced HL-60 popula-
tion (29). The latter observation, together with the detection
of X-CGD mRNA transcripts in fully mature peripheral
blood granulocytes, suggests that mature cells may maintain
some ongoing synthesis of the NADPH oxidase, rather than
stockpiling the necessary supply during the process of dif-
ferentiation.
The studies of transcription rates by nuclear runoff suggest
that expression of X-CGD is controlled at both the transcrip-
tional and posttranscriptional levels. The relative changes in
transcription rates are similar to those of steady-state mRNA
levels during the first day of induction. Thus, transcriptional
control appears to be important early in differentiation and
may be the dominant factor in the control of steady-state
mRNA. At days 3 and 4 of induced differentiation, the
change in the X-CGD transcription rate is less than the
increase in X-CGD mRNA, suggesting the operation of
posttranscriptional mechanisms, such as increased mRNA
stability, that might further increase the steady-state level of
the transcripts (particularly at day 4). These comparisons of
proportions are approximate, since experiment-to-exper-
iment variation makes exact overlap of the data impossible.
However, the direction and degree of observed changes
were reproducible and consistent.
The decrease in the transcription rate of c-myc in response
to RA-DMF can fully account for the decrease in steady-
state nyc mRNA during both short-term (24 h) and long-
term (5 days) incubation with RA-DMF and supports data
from other laboratories which demonstrate transcriptional
regulation of c-myc during differentiation of HL-60 cells (23,
37).
Expression of X-CGD in the G1 phase of the cell cycle in
undifferentiated cells could occur because X-CGD is cell
cycle controlled and hence preferentially expressed in G1.
Alternatively, the finding could represent expression of the
gene in the small number of cells spontaneously committed
to differentiate and blocked in G1-Go. Twenty-four hours
after HL-60 cells are induced to differentiate with RA, the
X-CGD mRNA is expressed equally strongly in every phase
of the cycle, indicating that the cell need not be in G1-Go, or
be morphologically and functionally mature, to express the
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X-CGD mRNA. The results of the experiment with HL-60
cells incubated for 2 days with RA-DMF before separation
into immature and mature fractions indicate that cells which
are induced but still morphologically undifferentiated ex-
press X-CGD mRNA as strongly as those already showing
morphologic change. Only fraction 5 cells, the most undif-
ferentiated, have lower levels of X-CGD mRNA. Thus, the
expression of X-CGD mRNA during granulocytic differenti-
ation appears to be independent of the cell cycle and to occur
in both proliferating and nonproliferating, and both morpho-
logically mature and immature cells.
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